Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacologic therapy for the hyperlipidemic patient.

D B Hunninghake

    The American Journal of Medicine
    |May 23, 1983
    PubMed
    Summary

    Drug therapy for lipid disorders should complement diet. Different medications like nicotinic acid, cholestyramine, and probucol target specific lipoprotein issues, but carry risks and varying efficacy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A summary of the findings from the Post-CABG trial.

    Minerva cardioangiologica·2002
    Same author

    Effect of an aggressive lipid-lowering strategy on progression of atherosclerosis in the left main coronary artery from patients in the post coronary artery bypass graft trial.

    Circulation·2001
    Same author

    Postdischarge lipid management of coronary artery disease patients according to the new National Cholesterol Education Program guidelines.

    The American journal of cardiology·2001
    Same author

    Roundtable discussion: therapeutic challenges and deficiencies.

    The American journal of cardiology·2001
    Same author

    Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease. The Heart and Estrogen/progestin Replacement Study.

    Annals of internal medicine·2001
    Same author

    Peripheral arterial disease detection, awareness, and treatment in primary care.

    JAMA·2001

    Area of Science:

    • Pharmacology
    • Cardiovascular Medicine
    • Lipidology

    Background:

    • Drug therapy for dyslipidemias requires established baseline lipid values and prior dietary intervention.
    • Various drug classes exist to manage lipoprotein disorders, each with specific indications and limitations.

    Purpose of the Study:

    • To review the efficacy and safety of commonly used drugs for treating lipoprotein disorders.
    • To highlight the risks and benefits associated with different lipid-lowering agents.

    Main Methods:

    • Review of existing literature on drug therapies for hyperlipoproteinemia.
    • Analysis of clinical trial data and epidemiological studies regarding drug safety and efficacy.

    Main Results:

    • Nicotinic acid is effective for most lipoprotein disorders, with flushing manageable by aspirin.
    • Cholestyramine and colestipol are indicated for type II hyperlipoproteinemia.
    • Clofibrate use has declined due to increased morbidity/mortality.
    • Dextrothyroxine is restricted to patients without atherosclerotic heart disease.
    • Probucol lowers LDL but also reduces HDL cholesterol.

    Conclusions:

    • The choice of drug therapy for lipid disorders must consider specific lipoprotein profiles, efficacy, and potential adverse effects.
    • Careful patient selection and monitoring are crucial for safe and effective lipid-lowering drug use.

    Related Experiment Videos